[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343536-105":59,"doc-detail-343536-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ewing-sarcoma-in-the-pediatric-population-predictors-of-survival-within-the-united-states","Ewing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States","","Ewing sarcoma is a major cause of pediatric cancer mortality in the United States, and survival improvements have plateaued despite advances in molecular characterization. This study updates 5-year survival rates and identifies predictors of survival for pediatric Ewing sarcoma of bone treated in the U.S. Using the National Cancer Database with retrospective inquiry, investigators analyzed cases from the most updated bone and joint public use file and applied Cox proportional hazards regression with validation on both truncated and full cohorts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ewing-sarcoma-in-the-pediatric-population-predictors-of-survival-within-the-united-states/343536/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ewing-sarcoma-in-the-pediatric-population-predictors-of-survival-within-the-united-states/343536.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of this investigation?","Question",{"text":112,"@type":113},"To determine updated 5-year survival rates and predictors of survival for pediatric Ewing sarcoma of bone treated within the United States.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the data and survival analysis conducted?",{"text":117,"@type":113},"Investigators retrospectively queried the National Cancer Database for pediatric Ewing sarcoma cases, truncated to patients with reported 5-year vital status, then used Cox proportional hazards regression to validate findings and perform univariate and multivariable regression.",{"name":119,"@type":110,"acceptedAnswer":120},"What predictors were associated with worse mortality?",{"text":121,"@type":113},"Multivariable predictors of worse mortality included older age, larger tumor size (0.8 cm), macrometastatic disease at presentation, and positive surgical margins.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343536,1790837798,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Research Article  \nEwing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States  \nMatthew E. Wells, DO  Michael D. Eckhoff, MD William Davis, Pharm D Vishwajeet Singh, PhD Rajiv Rajani, MD Elizabeth M. Polfer, MD  \nFrom the Department of Orthopedic Surgery, William Beaumont Army Medical Center (Dr. Wells, Dr. Eckhoff, and Dr. Polfer); the Department of Orthopedic Surgery, Texas Tech University Health Sciences Center El Paso (Dr. Wells, Dr. Eckhoff, Dr. Davis, Dr. Rajani, and Dr. Polfer); and Biostatistics and Epidemiology Consulting Lab, Texas Tech University Health Sciences Center El Paso, El Paso, TX (Dr. Singh) .  \nCorrespondence to Dr. Wells: matthew.eric. [wells@gmail.com](wells@gmail.com)  \nNone of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article:  \nDr. Wells, Dr. Eckhoff, Dr. Davis, Dr. Singh, Dr. Rajani, and Dr. Polfer.  \nDr. Eckhoff: The author assisted in formatting the manuscript with a literature review and manuscript compilation. Dr. Davis: The author assisted in formatting the manuscript with a literature review and manuscript compilation.  \nDr. Singh: The author provided expert statistical analysis and table/figure generation. Dr. Rajani: The author gave expert guidance with formal review and assistance in the revisions. Dr. Polfer:  \nThe author gave expert guidance with formal review and assistance in the revisions.  \nJAAOS Glob Res Rev 2024;8: e24 .00281 DOI: 10.5435/JAAOSGlobal-D-24-00281  \nCopyright 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Orthopaedic Surgeons. This is an open access article distributed under the Creative Commons Attribution License 4 .  \n0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  \nABSTRACT  \nIntroduction: Bone andjointtumors arethethird most common cause of pediatriccancer–related deaths in the United States. Although there have been improvements in survival rates among pediatric cancer patients over the past few decades, bone and joint cancers remain the exception. Considering current clinical trials involving novel targeted therapies, the establishment of updated mortality rates and predictors of survival for this cancer would be prudent. This investigation sought to determine updated 5-year survival rates and predictors of survival among pediatric Ewing sarcoma (ES) of bone treated within the United States. Methods: The National Cancer Database was retrospectively inquired for all pediatric ES cases within the most updated bone and joint public use file available in September 2022. The reported data were truncated to only include patients with reported 5-year vital (ie, survival) status. Cox proportional hazard regression was conducted on both the truncated data and the entire cohort to validate the findings. The patients were then separated into alive versus deceased cohorts, and univariate regression analysis was done followed by multivariable regression of notable variables of interest.  \nResults: Overall, an aggregated 5-year survival rate of 74 .5% was found in the included patient cohort. Patients with localized cancer had a comparatively improved 5-year survival rate of 84.70% as opposed to those with macrometastatic disease on presentation with a survival rate of 50.4% . Patient demographic-, tumor-, and treatment-specific variables all demonstrated an effect on survival. The multivariable predictors of worse mortality were found to include older age, larger tumor size (.8 cm), macrometastatic disease on presentation, and positive surgical margins.  \nConclusion: This analysis serves to establish updated survival rates of pediatric ES treated within the United States to set standards for comparison among future studies. Continued mult","cbCaimr0i59TdBJT","https://ap.wps.com/l/cbCaimr0i59TdBJT","pdf",549061,13,"English","# Abstract\n## Introduction\n## Methods\n## Results\n## Conclusion\n# Pediatric Ewing Sarcoma\n## Background and epidemiology\n## Molecular characterization and treatment overview","[{\"question\":\"What was the purpose of this investigation?\",\"answer\":\"To determine updated 5-year survival rates and predictors of survival for pediatric Ewing sarcoma of bone treated within the United States.\"},{\"question\":\"How were the data and survival analysis conducted?\",\"answer\":\"Investigators retrospectively queried the National Cancer Database for pediatric Ewing sarcoma cases, truncated to patients with reported 5-year vital status, then used Cox proportional hazards regression to validate findings and perform univariate and multivariable regression.\"},{\"question\":\"What predictors were associated with worse mortality?\",\"answer\":\"Multivariable predictors of worse mortality included older age, larger tumor size (0.8 cm), macrometastatic disease at presentation, and positive surgical margins.\"}]","Ewing Sarcoma in the Pediatric Population: Predictors of Survival Within the United States | PDF",1790051401,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c1d470f17fd97dc96083e1ebcab3242.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f36a47a334062c7e7eab5d87b891828e.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/089e540ef83a9b9fc72713d5096eee8e.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/745968706d2d5cd4ec39533b83f06fd8.webp",980,1292]